More about compounding concerns An open letter from Eli Lilly and Company regarding certain practices related to Mounjaro and Zepbound (June 2024) FDA warns about adverse events from compounded semaglutide (May 2023) Novo Nordisk escalates legal actions to safeguard patients from potentially harmful compounded semaglutide drugs (May 2024) The Center for Medicine in the Public Interest's September 2025 handout explains concerns about mass compounding
Ghosh P, Fontanella RA, Scisciola L, Pesapane A, Taktaz F, Franzese M, et al
Slow down the rate at which food leaves your stomach, keeping you full longer
If you miss more than two weeks, most providers recommend stepping back one dose level and re-titrating over two to four weeks
cAMP accumulation assay cAMP accumulation assay was performed as described previously(Hager et al
They are harder to digest and may contribute to GI symptoms